Metabolic Fuels Study
Completed · Not applicable
Conditions studied: Obesity
In brief
This study will evaluate a potential physiologic mechanism underlying the effects of dietary composition on control of body weight
Key facts
- Study ID
- NCT02235038
- Run by
- Boston Children's Hospital
- People needed
- 30
- Starts
- 2014-10-01
- Expected to finish
- 2017-05-01
- Last updated by the study team
- 2017-07-21
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Inclusion Criteria (as detailed in Framingham State Food Study, NCT02068885)
- Aged 18 to 65 years
- BMI ≥ 25 kg/m2
- BMI < 40 kg/m2 and weight ≤ 300 lbs (136 kg)
- Medical clearance from a primary care provider
- Student or employee at Framingham State University throughout enrollment in the study
- Willing and able to eat and drink only the foods and beverages on the study menus
- Willing to eat in the dining hall
- Willing to abstain from consuming alcohol during participation
- Additional Inclusion Criteria:
- Willing to undergo additional procedures in this ancillary study
You may not qualify if…
- Exclusion Criteria (as detailed in Framingham State Food Study, NCT02068885)
- Change in body weight exceeding ±10% during prior year
- Recent adherence to a special diet
- Recent adherence to a vigorous physical activity regimen (e.g., participation in a varsity sport)
- Chronic use of any medication or dietary supplement that could affect study outcomes
- Current smoking (1 cigarette in the last week)
- Heavy baseline alcohol consumption or history of binge drinking
- Physician diagnosis of a major medical/psychiatric illness or eating disorder
- Abnormal blood glucose, TSH, CBC, BUN, Creatinine
- ALT greater than 150% of the normal upper limit
- Plans for a vacation during the study that would preclude adherence to prescribed diet
- Additional exclusions for female participants: Irregular menstrual cycles; any change in birth control medication during the 3 months prior to enrollment; pregnancy or lactation during the 12 months prior to enrollment
- Additional Exclusion Criteria:
- Allergy or prior reaction to Lidocaine
- Medical condition or medication that would increase risk of bleeding, infection or skin reactions
Where it is running
- Boston Children's Hospital — Boston, Massachusetts, United States
- Brigham & Women's Hospital — Boston, Massachusetts, United States
- Boston Medical Center — Boston, Massachusetts, United States
- Framingham State University — Framingham, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.